Brexpiprazole versus placebo for people with schizophrenia-Reference-Cited by-同舟云学术

Brexpiprazole versus placebo for people with schizophrenia

Published:2017-03-04 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Bazrafshan Azam¹,Zare Morteza²,Bazrafshan Maliheh³,Zare Fatemeh⁴,Mazhari Shahrzad¹

Affiliation:

1. Kerman University of Medical Sciences; Neuroscience Research Center, Institute of Neuropharmacology; Kerman Iran

2. Shiraz University of Medical Sciences; Nutrition Research Center, School of Nutrition and Food Sciences; Shiraz Iran

3. Kerman University of Medical Sciences; Department of Epidemiology, School of Public Health; Haft Bagh Highway Kerman University of Medical Sciences Campus Kerman Iran

4. Shiraz University of Medical Sciences; School of Pharmacy; Karimkhan Blvd Shiraz Iran

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012580/epdf/full

Reference39 articles.

1. Detecting skewness from summary information;Altman;BMJ,1996

2. Statistics notes. Trials randomised in clusters;Bland;BMJ,1997

3. The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use;Boissel;Therapie,1999

4. Schizophrenia: moving beyond monoamine antagonists;Conn;Molecular Interventions,2008

5. Efficacy and safety of brexpiprazole for the treatment of acute schizophrenia: a six-week randomized, double-blind, placebo-controlled trial;Correll;American Journal of Psychiatry,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aripiprazole versus brexpiprazole for people with schizophrenia;Cochrane Database of Systematic Reviews;2023-02-17